Current Report Filing (8-k)
11 Mai 2022 - 10:31PM
Edgar (US Regulatory)
false000089626400008962642022-05-112022-05-11
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
May 11, 2022
USANA HEALTH SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Utah
(State or other jurisdiction of incorporation)
|
001-35024
|
|
87-0500306
|
|
(Commission File No.)
|
|
(IRS Employer
Identification No.)
|
3838 West Parkway Boulevard
Salt Lake City,
Utah 84120
(Address of principal executive offices, Zip Code)
Registrant's telephone number, including area code: (801) 954-7100
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
|
Common Stock, $0.001 par value per share
|
|
USNA
|
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined
in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission
of Matters to a Vote of Security Holders.
The Company held its Annual Meeting of Shareholders on May 9, 2022. A total of 17,371,833 shares (approximately 91%) of the issued and outstanding shares of
USANA common stock were represented by proxy or in person at the meeting. The following matters were submitted and voted upon at the Annual Meeting:
|
1.
|
USANA shareholders voted to elect seven individuals to the Board of Directors for the succeeding year as set forth below:
|
|
Name
|
|
Number of
Shares For
|
|
Number of
Shares
Withheld
|
|
Number of
Shares
Abstaining
|
|
Broker Non-
Votes
|
|
Kevin G. Guest
|
|
16,083,445
|
|
372,982
|
|
-
|
|
915,406
|
|
Xia Ding
|
|
16,423,086
|
|
33,341
|
|
-
|
|
915,406
|
|
John T. Fleming
|
|
16,253,450
|
|
202,977
|
|
-
|
|
915,406
|
|
Gilbert A. Fuller
|
|
16,093,247
|
|
363,180
|
|
-
|
|
915,406
|
|
Peggie J. Pelosi
|
|
16,237,746
|
|
218,681
|
|
-
|
|
915,406
|
|
Frederic Winssinger
|
|
16,168,204
|
|
288,223
|
|
-
|
|
915,406
|
|
Timothy E. Wood, Ph.D.
|
|
16,256,811
|
|
199,616
|
|
-
|
|
915,406
|
|
2.
|
USANA shareholders voted to ratify the Board’s selection of KPMG LLP as our independent registered public accounting firm for fiscal year 2022 as set forth below:
|
|
Number of
Shares For
|
|
Number of
Shares
Against
|
|
Number of
Shares
Abstaining
|
|
Broker Non-
Votes
|
|
17,335,468
|
|
31,969
|
|
4,396
|
|
-
|
| |
|
|
|
3.
|
USANA shareholders voted to approve, on an advisory basis, executive compensation as set forth below:
|
|
Number of
Shares For
|
|
Number of
Shares
Against
|
|
Number of
Shares
Abstaining
|
|
Broker Non-
Votes
|
|
15,716,955
|
|
728,187
|
|
11,285
|
|
915,406
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
USANA HEALTH SCIENCES, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ G. Douglas Hekking
|
|
|
|
|
|
|
|
|
G. Douglas Hekking, Chief Financial Officer
|
|
Date: May 11, 2022
3
USANA Health Sciences (NYSE:USNA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
USANA Health Sciences (NYSE:USNA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024
